Literature DB >> 25466513

Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence of dementia and cognitive impairment in a population of 70-74-year olds: the InveCe.Ab study.

Antonio Guaita1, Roberta Vaccaro2, Annalisa Davin3, Mauro Colombo2, Silvia Francesca Vitali2, Letizia Polito3, Simona Abbondanza3, Eleonora Valle2, Gianluigi Forloni4, Virginia Valeria Ferretti5, Simona Villani5.   

Abstract

The age-specific prevalence rates of dementia vary widely. Studies focusing on specific age groups are needed to provide reliable estimates for healthcare providers and policy makers. We estimated the prevalence of dementia, dementia subtypes and cognitive impairment in "InveCe.Ab" (ClinicalTrials.gov, NCT01345110), a single-step multidimensional population-based study of 70-74-year olds living in Abbiategrasso (Milan, Italy). We also looked for associations with socio-demographic factors and the presence of the apolipoprotein E-ɛ4 allele. The overall dementia prevalence was 3% (95%CI: 2.1-4.1%) [Alzheimer's disease (AD): 1.2% (95%CI 0.6-1.9%); vascular dementia (VD): 1.4% (95%CI: 0.8-2.2%)]. Being single was found to be a risk factor for vascular dementia; subjects born in southern Italy were shown to be at greater risk both of overall dementia and of vascular dementia. The prevalence of cognitive impairment, with or without subjective cognitive complaints (cognitive impairment, no dementia, CIND) was 7.8% (95%CI: 6.4-9.4%). As regards the CIND subgroups, the prevalence of subjects with subjective cognitive complaints (mild cognitive impairment, MCI) was 5.0% (95%CI 3.9-6.3%), while the prevalence of those without MCI (CIND-other) was 2.8% (95%CI: 1.9-3.8). The males had a higher risk of MCI and CIND-other; the older subjects were more likely to have MCI, and those born in north-eastern Italy to have CIND-other. The prevalence of AD was higher among the apolipoprotein E-ɛ4 carriers. Our data highlight the importance of dementia and cognitive impairment in the transitional period from adulthood to old age, and reveal the presence of different associations with socio-demographic and genetic factors.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; ApoE-ɛ4; Cognitive impairment; Dementia; Prevalence; Risk factors

Mesh:

Substances:

Year:  2014        PMID: 25466513     DOI: 10.1016/j.archger.2014.11.006

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  12 in total

Review 1.  Relationship between cognitive function and regulation of cerebral blood flow.

Authors:  Shigehiko Ogoh
Journal:  J Physiol Sci       Date:  2017-02-03       Impact factor: 2.781

2.  Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Ronald C Petersen; Oscar Lopez; Melissa J Armstrong; Thomas S D Getchius; Mary Ganguli; David Gloss; Gary S Gronseth; Daniel Marson; Tamara Pringsheim; Gregory S Day; Mark Sager; James Stevens; Alexander Rae-Grant
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

Review 3.  Spousal caregiving, widowhood, and cognition: A systematic review and a biopsychosocial framework for understanding the relationship between interpersonal losses and dementia risk in older adulthood.

Authors:  E Lydia Wu-Chung; Stephanie L Leal; Bryan T Denny; Samantha L Cheng; Christopher P Fagundes
Journal:  Neurosci Biobehav Rev       Date:  2021-12-29       Impact factor: 8.989

4.  Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.

Authors:  Alba Malara; Giuseppe Andrea De Biase; Francesco Bettarini; Francesco Ceravolo; Serena Di Cello; Michele Garo; Francesco Praino; Vincenzo Settembrini; Giovanni Sgrò; Fausto Spadea; Vincenzo Rispoli
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

5.  Subthreshold Depression and Clinically Significant Depression in an Italian Population of 70-74-Year-Olds: Prevalence and Association with Perceptions of Self.

Authors:  Roberta Vaccaro; Paola Borrelli; Simona Abbondanza; Annalisa Davin; Letizia Polito; Mauro Colombo; Silvia Francesca Vitali; Simona Villani; Antonio Guaita
Journal:  Biomed Res Int       Date:  2017-03-14       Impact factor: 3.411

6.  Prospective associations between pulse pressure and cognitive performance in Chinese middle-aged and older population across a 5-year study period.

Authors:  Tingting Sha; Wenwei Cheng; Yan Yan
Journal:  Alzheimers Res Ther       Date:  2018-03-12       Impact factor: 6.982

7.  Marriage and risk of dementia: systematic review and meta-analysis of observational studies.

Authors:  Andrew Sommerlad; Joshua Ruegger; Archana Singh-Manoux; Glyn Lewis; Gill Livingston
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-11-28       Impact factor: 13.654

8.  Differential moderation effects of ApoE and 5-HTTLPR genotypes on social vulnerability in predicting mortality among community-dwelling middle-aged and older adults: a nationwide population-based study.

Authors:  Hsin-Yu Liu; Li-Ning Peng; Wei-Ju Lee; Ming-Yueh Chou; Chih-Kuang Liang; Fei-Yuan Hsiao; Ming-Hsien Lin; Liang-Kung Chen
Journal:  Aging (Albany NY)       Date:  2021-10-14       Impact factor: 5.682

9.  The Efficacy of Cognitive Training for Elderly Chinese Individuals with Mild Cognitive Impairment.

Authors:  Zhenren Peng; Hu Jiang; Xiaomin Wang; Kaiyong Huang; Yukun Zuo; Xiangmin Wu; Abu S Abdullah; Li Yang
Journal:  Biomed Res Int       Date:  2019-11-30       Impact factor: 3.246

10.  The Prevalence of Amnestic and Non-Amnestic Mild Cognitive Impairment and Its Association with Different Lifestyle Factors in a South Italian Elderly Population.

Authors:  Alessandro Oronzo Caffò; Giuseppina Spano; Luigi Tinella; Antonella Lopez; Elisabetta Ricciardi; Fabrizio Stasolla; Andrea Bosco
Journal:  Int J Environ Res Public Health       Date:  2022-03-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.